Using machine learning to classify the immunosuppressive activity of per- and polyfluoroalkyl substances.

Journal: Toxicology mechanisms and methods
PMID:

Abstract

Per- and polyfluoroalkyl substances (PFASs), one of the persistent organic pollutants, have immunosuppressive effects. The evaluation of this effect has been the focus of regulatory toxicology. In this investigation, 146 PFASs (immunosuppressive or nonimmunosuppressive) and corresponding concentration gradients were collected from literature, and their structures were characterized by using Dragon descriptors. Feature importance analysis and stepwise feature elimination are used for feature selection. Three machine learning (ML) methods, namely Random Forest (RF), Extreme Gradient Boosting Machine (XGB), and Categorical Boosting Machine (CB), were utilized for model development. The model interpretability was explored by feature importance analysis and correlation analysis. The findings indicated that the three models developed have exhibited excellent performance. Among them, the best-performing RF model has an average AUC score of 0.9720 for the testing set. The results of the feature importance analysis demonstrated that concentration, SpPosA_X, IVDE, R2s, and SIC2 were the crucial molecular features. Applicability domain analysis was also performed to determine reliable prediction boundaries for the model. In conclusion, this study is the first application of ML models to investigate the immunosuppressive activity of PFASs. The variables used in the models can help understand the mechanism of the immunosuppressive activity of PFASs, allow researchers to more effectively assess the immunosuppressive potential of a large number of PFASs, and thus better guide environmental and health risk assessment efforts.

Authors

  • Yuxin Xuan
    College of Public Health, Zhengzhou University, Zhengzhou, P. R. China.
  • Yulu Wang
    College of Public Health, Zhengzhou University, Zhengzhou, P. R. China.
  • Rui Li
    Department of Oncology, Xiyuan Hospital, China Academy of Chinese Medical Science, Beijing, China.
  • Yuyan Zhong
    College of Public Health, Zhengzhou University, Zhengzhou, P. R. China.
  • Na Wang
    College of Architecture and Civil Engineering, Xi'an University of Science and Technology Xi'an 710054 Shaanxi China wangna811221@xust.edu.cn +86-29-82202335 +86-29-82203378.
  • Lingyin Zhang
    College of Public Health, Zhengzhou University, Zhengzhou, P. R. China.
  • Qian Chen
    Department of Pain Medicine Guizhou Provincial Orthopedics Hospital Guiyang Guizhou China.
  • Shuling Yu
    Key Laboratory of Natural Medicine and Immune-Engineering of Henan Province, Henan University, Kaifeng, Henan, P. R. China.
  • Jintao Yuan
    College of Public Health, Zhengzhou University, Zhengzhou, P. R. China.